These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12495790)

  • 1. Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program.
    Green CA; Polen MR; Dickinson DM; Lynch FL; Bennett MD
    J Subst Abuse Treat; 2002 Dec; 23(4):285-95. PubMed ID: 12495790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of substance abuse treatment retention among women and men in an HMO.
    Mertens JR; Weisner CM
    Alcohol Clin Exp Res; 2000 Oct; 24(10):1525-33. PubMed ID: 11045861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in outcomes in an HMO-based substance abuse treatment program.
    Green CA; Polen MR; Lynch FL; Dickinson DM; Bennett MD
    J Addict Dis; 2004; 23(2):47-70. PubMed ID: 15132342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; Morse SA; MacMaster S
    Subst Use Misuse; 2015 Apr; 50(5):653-63. PubMed ID: 25587672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicaid patients in a private health maintenance organization: patterns of chemical dependency treatment.
    Walter LJ; Parthasarathy S; Allen S; Ackerson L
    J Behav Health Serv Res; 2002 Feb; 29(1):1-14. PubMed ID: 11840901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting the initiation of substance abuse treatment in managed care.
    Weisner C; Mertens J; Tam T; Moore C
    Addiction; 2001 May; 96(5):705-16. PubMed ID: 11331029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of residential treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; MacMaster SA; Seiters J
    J Psychoactive Drugs; 2013; 45(2):122-31. PubMed ID: 23909000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of an outpatient program for women with substance use-related disorders on retention.
    Zilberman ML; Tavares H; Andrade AG; El-Guebaly N
    Subst Use Misuse; 2003 Dec; 38(14):2109-24. PubMed ID: 14677784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adolescents with substance diagnoses in an HMO: factors associated with medical provider referrals to substance abuse and mental health treatment.
    Scott M; Parthasarathy S; Kohn C; Hinman A; Sterling S; Weisner C
    Ment Health Serv Res; 2004 Mar; 6(1):47-60. PubMed ID: 15002680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting attrition in long-term residential substance use disorder treatment: A modifiable risk factors perspective.
    Baker DE; Edmonds KA; Calvert ML; Sanders SM; Bridges AJ; Rhea MA; Kosloff S
    Psychol Serv; 2020 Nov; 17(4):472-482. PubMed ID: 30816739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in problem severity at assessment and treatment retention.
    Arfken CL; Klein C; di Menza S; Schuster CR
    J Subst Abuse Treat; 2001 Jan; 20(1):53-7. PubMed ID: 11239728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Client retention in residential drug treatment for Latinos.
    Amodeo M; Chassler D; Oettinger C; Labiosa W; Lundgren LM
    Eval Program Plann; 2008 Feb; 31(1):102-12. PubMed ID: 18222144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in substance use treatment entry and retention among prisoners with substance use histories.
    Pelissier B
    Am J Public Health; 2004 Aug; 94(8):1418-24. PubMed ID: 15284053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls.
    Mertens JR; Lu YW; Parthasarathy S; Moore C; Weisner CM
    Arch Intern Med; 2003 Nov; 163(20):2511-7. PubMed ID: 14609789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation and retention in drug abuse treatment services research.
    Vaughn T; Sarrazin MV; Saleh SS; Huber DL; Hall JA
    J Subst Abuse Treat; 2002 Dec; 23(4):387-97. PubMed ID: 12495801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in Afghan drug-abuse treatment: an assessment of treatment entry characteristics, dropout, and outcomes.
    Abadi MH; Shamblen SR; Courser M; Johnson KW; Thompson K; Young L; Browne T
    Ethn Health; 2015; 20(5):453-73. PubMed ID: 24920072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization and costs of substance abuse services within The HMO Group.
    Levin BL
    HMO Pract; 1993 Mar; 7(1):28-34. PubMed ID: 10171407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual abuse, parental bonding, social support, and program retention for women in substance abuse treatment.
    Cosden M; Cortez-Ison E
    J Subst Abuse Treat; 1999 Mar; 16(2):149-55. PubMed ID: 10023613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spirituality, sense of coherence, and coping responses in women receiving treatment for alcohol and drug addiction.
    Arévalo S; Prado G; Amaro H
    Eval Program Plann; 2008 Feb; 31(1):113-23. PubMed ID: 17825910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences by Gender in Predictors of Motivation Among Substance Abuse Treatment Participants.
    Taylor LR; Caudy M; Blasko BL; Taxman FS
    Subst Use Misuse; 2017 Mar; 52(4):468-476. PubMed ID: 28001464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.